Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Finasteride shows promise for female hair loss, but more research needed.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.